Prescribing anti-amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions.
作者信息
Greenberg Barry D, Lemere Cynthia A, Barnes Lisa L, Hayden Kathleen M, Kukull Walter A, Oh Esther S, Snyder Peter J, Supiano Mark, Dilworth-Anderson Peggye
机构信息
Department of Neurology Johns Hopkins University School of Medicine Baltimore Maryland USA.
Ann Romney Center for Neurologic Diseases Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
出版信息
Alzheimers Dement (N Y). 2023 Oct 4;9(4):e12426. doi: 10.1002/trc2.12426. eCollection 2023 Oct-Dec.
Abstract
摘要
相似文献
1
Prescribing anti-amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions.开抗淀粉样蛋白免疫疗法治疗阿尔茨海默病：充分告知患者以助其做出决策。
Alzheimers Dement (N Y). 2023 Oct 4;9(4):e12426. doi: 10.1002/trc2.12426. eCollection 2023 Oct-Dec.
2
Commentary on Greenberg et al., "Prescribing anti-amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions" [. 2023; 9(4):e12426. doi.org/10.1002/trc2.12426].对格林伯格等人所著《开具抗淀粉样蛋白免疫疗法治疗阿尔茨海默病：充分告知患者决策》的评论[. 2023; 9(4):e12426. doi.org/10.1002/trc2.12426]
Alzheimers Dement (N Y). 2024 Jan 26;10(1):e12443. doi: 10.1002/trc2.12443. eCollection 2024 Jan-Mar.
3
Open peer commentary on "Prescribing anti-amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions".关于“开具抗淀粉样蛋白免疫疗法治疗阿尔茨海默病：充分告知患者决策”的公开同行评论
Alzheimers Dement (N Y). 2023 Nov 20;9(4):e12437. doi: 10.1002/trc2.12437. eCollection 2023 Oct-Dec.
4
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects.阿尔茨海默病中的高清除率抗淀粉样蛋白免疫疗法。第1部分：疗效和安全性数据的荟萃分析与综述以及医学经济学方面
Rev Neurol (Paris). 2022 Dec;178(10):1011-1030. doi: 10.1016/j.neurol.2022.06.012. Epub 2022 Sep 29.
5
Immunotherapies for Alzheimer's Disease-A Review.阿尔茨海默病的免疫疗法——综述
Vaccines (Basel). 2022 Sep 14;10(9):1527. doi: 10.3390/vaccines10091527.
6
Editorial: Targets for Disease-Modifying Therapies in Alzheimer's Disease, Including Amyloid β and Tau Protein.社论：阿尔茨海默病的疾病修饰治疗靶点，包括淀粉样 β 和tau 蛋白。
Med Sci Monit. 2021 Jul 26;27:e934077. doi: 10.12659/MSM.934077.
7
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 2: putative scenarios and timeline in case of approval, recommendations for use, implementation, and ethical considerations in France.阿尔茨海默病中的高清除率抗淀粉样蛋白免疫疗法。第2部分：获批后的假定情况和时间线、法国的使用建议、实施及伦理考量
Rev Neurol (Paris). 2022 Dec;178(10):999-1010. doi: 10.1016/j.neurol.2022.08.002. Epub 2022 Nov 3.
8
Developing injectable immunoglobulins to treat cognitive impairment in Alzheimer's disease.开发用于治疗阿尔茨海默病认知障碍的注射用免疫球蛋白。
Expert Opin Biol Ther. 2008 May;8(5):633-42. doi: 10.1517/14712598.8.5.633.
9
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?针对阿尔茨海默病的淀粉样蛋白免疫疗法还有希望吗？
Curr Opin Psychiatry. 2014 Mar;27(2):128-37. doi: 10.1097/YCO.0000000000000041.
10
Photo-oxygenation by a biocompatible catalyst reduces amyloid-β levels in Alzheimer's disease mice.光氧作用通过生物相容的催化剂降低阿尔茨海默病小鼠中的淀粉样-β水平。
Brain. 2021 Jul 28;144(6):1884-1897. doi: 10.1093/brain/awab058.
引用本文的文献
1
Evaluation of efficiency and effectiveness of different recruitment strategies for the FINGER-NL multidomain lifestyle intervention trial via the Dutch Brain Research Registry.通过荷兰脑研究登记处评估FINGER-NL多领域生活方式干预试验不同招募策略的效率和效果。
Alzheimers Dement (N Y). 2025 Jan 9;11(1):e70017. doi: 10.1002/trc2.70017. eCollection 2025 Jan-Mar.
2
Commentary on Greenberg et al., "Prescribing anti-amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions" [. 2023; 9(4):e12426. doi.org/10.1002/trc2.12426].对格林伯格等人所著《开具抗淀粉样蛋白免疫疗法治疗阿尔茨海默病：充分告知患者决策》的评论[. 2023; 9(4):e12426. doi.org/10.1002/trc2.12426]
Alzheimers Dement (N Y). 2024 Jan 26;10(1):e12443. doi: 10.1002/trc2.12443. eCollection 2024 Jan-Mar.
3
One step forward to personalized medicine?向个性化医疗迈进了一步？
Alzheimers Dement (N Y). 2023 Nov 15;9(4):e12435. doi: 10.1002/trc2.12435. eCollection 2023 Oct-Dec.
4
Open peer commentary on "Prescribing anti-amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions".关于“开具抗淀粉样蛋白免疫疗法治疗阿尔茨海默病：充分告知患者决策”的公开同行评论
Alzheimers Dement (N Y). 2023 Nov 20;9(4):e12437. doi: 10.1002/trc2.12437. eCollection 2023 Oct-Dec.
本文引用的文献
1
Alzheimer's drug trials plagued by lack of racial diversity.阿尔茨海默病药物试验因缺乏种族多样性而饱受困扰。
Nature. 2023 Aug;620(7973):256-257. doi: 10.1038/d41586-023-02464-1.
2
Preparing for disease-modifying therapies in Alzheimer's disease.为阿尔茨海默病的疾病修饰治疗做准备。
Lancet Neurol. 2023 Sep;22(9):782-783. doi: 10.1016/S1474-4422(23)00274-0. Epub 2023 Jul 16.
3
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.多奈哌齐治疗早期症状性阿尔茨海默病的随机临床试验。
JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239.
4
Donanemab for Alzheimer Disease-Who Benefits and Who Is Harmed?用于治疗阿尔茨海默病的多奈单抗——谁会受益，谁会受损？
JAMA. 2023 Aug 8;330(6):510-511. doi: 10.1001/jama.2023.11704.
5
Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease.用于阿尔茨海默病的淀粉样蛋白靶向单克隆抗体
JAMA. 2023 Aug 8;330(6):507-509. doi: 10.1001/jama.2023.11703.
6
Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease.评估用于阿尔茨海默病的抗淀粉样蛋白免疫疗法的关键问题。
Brain Commun. 2023 Jun 2;5(3):fcad175. doi: 10.1093/braincomms/fcad175. eCollection 2023.
7
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients.用于治疗阿尔茨海默病的抗淀粉样蛋白疗法：终于，给患者带来了好消息。
Mol Neurodegener. 2023 Jun 28;18(1):42. doi: 10.1186/s13024-023-00637-0.
8
Lecanemab: Appropriate Use Recommendations.仑卡奈单抗：合理使用建议。
J Prev Alzheimers Dis. 2023;10(3):362-377. doi: 10.14283/jpad.2023.30.
9
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
10
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study.轻度认知障碍或痴呆个体中淀粉样蛋白PET阳性的种族和民族差异：淀粉样蛋白扫描成像痴呆证据（IDEAS）队列研究的二次分析
JAMA Neurol. 2022 Oct 3;79(11):1139-47. doi: 10.1001/jamaneurol.2022.3157.
Zotero 插件